Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- New Study Demonstrates That Xangold® Natural Lutein Ester Supplements May Benefit Those With Early Stage Macular Degeneration
- New Study Demonstrates That Xangold® Natural Lutein Ester Supplements May Benefit Those With Early Stage Macular Degeneration
- Chrysantis(TM), Inc. Responds to Lutein, Zeaxanthin Study
Company reponds to interpretation of study results published in the Journal of Nutrition (135:1763-1769, July 2005) regarding lutein and zeaxanthin.
- Chrysantis(TM), Inc. Responds to Lutein, Zeaxanthin Study
Company reponds to interpretation of study results published in the Journal of Nutrition (135:1763-1769, July 2005) regarding lutein and zeaxanthin.
- Chrysantis(TM), Inc. Responds to Lutein, Zeaxanthin Study
Company reponds to interpretation of study results published in the Journal of Nutrition (135:1763-1769, July 2005) regarding lutein and zeaxanthin.
- Higher Dietary DHA/EPA Omega-3 Fatty Acids Associated with Lessened Progression in Age-related Vision Loss
Dr. J. P. SanGiovanni reported this afternoon, at the ISSFAL Congress in Cairns, Australia, on the relationship of dietary omega-3 intakes as DHA/EPA, found mainly in fish, to the deterioration in visual performance with aging.
- Higher Dietary DHA/EPA Omega-3 Fatty Acids Associated with Lessened Progression in Age-related Vision Loss
Dr. J. P. SanGiovanni reported this afternoon, at the ISSFAL Congress in Cairns, Australia, on the relationship of dietary omega-3 intakes as DHA/EPA, found mainly in fish, to the deterioration in visual performance with aging.
- Higher Dietary DHA/EPA Omega-3 Fatty Acids Associated with Lessened Progression in Age-related Vision Loss
Dr. J. P. SanGiovanni reported this afternoon, at the ISSFAL Congress in Cairns, Australia, on the relationship of dietary omega-3 intakes as DHA/EPA, found mainly in fish, to the deterioration in visual performance with aging.
- Higher Dietary DHA/EPA Omega-3 Fatty Acids Associated with Lessened Progression in Age-related Vision Loss
Dr. J. P. SanGiovanni reported this afternoon, at the ISSFAL Congress in Cairns, Australia, on the relationship of dietary omega-3 intakes as DHA/EPA, found mainly in fish, to the deterioration in visual performance with aging.
- Higher Dietary DHA/EPA Omega-3 Fatty Acids Associated with Lessened Progression in Age-related Vision Loss
Dr. J. P. SanGiovanni reported this afternoon, at the ISSFAL Congress in Cairns, Australia, on the relationship of dietary omega-3 intakes as DHA/EPA, found mainly in fish, to the deterioration in visual performance with aging.
- Higher Dietary DHA/EPA Omega-3 Fatty Acids Associated with Lessened Progression in Age-related Vision Loss
Dr. J. P. SanGiovanni reported this afternoon, at the ISSFAL Congress in Cairns, Australia, on the relationship of dietary omega-3 intakes as DHA/EPA, found mainly in fish, to the deterioration in visual performance with aging.
- Higher Dietary DHA/EPA Omega-3 Fatty Acids Associated with Lessened Progression in Age-related Vision Loss
Dr. J. P. SanGiovanni reported this afternoon, at the ISSFAL Congress in Cairns, Australia, on the relationship of dietary omega-3 intakes as DHA/EPA, found mainly in fish, to the deterioration in visual performance with aging.
- Higher Dietary DHA/EPA Omega-3 Fatty Acids Associated with Lessened Progression in Age-related Vision Loss
Dr. J. P. SanGiovanni reported this afternoon, at the ISSFAL Congress in Cairns, Australia, on the relationship of dietary omega-3 intakes as DHA/EPA, found mainly in fish, to the deterioration in visual performance with aging.
- Higher Dietary DHA/EPA Omega-3 Fatty Acids Associated with Lessened Progression in Age-related Vision Loss
Dr. J. P. SanGiovanni reported this afternoon, at the ISSFAL Congress in Cairns, Australia, on the relationship of dietary omega-3 intakes as DHA/EPA, found mainly in fish, to the deterioration in visual performance with aging.
- Study: Astaxanthin Prevents the Onset Of Asthenopia
Company announces the publication of the ninth clinical study on AstaReal® astaxanthin for the reduction of asthenopia (eye fatigue). The effects of astaxanthin on eyestrain induced by accommodative dysfunction were investigated at the University of Occupational and Environmental Health, Department of Ophthalmology, Japan. Results showed a significant improvement in the astaxanthin supplemented group over the placebo group.
- Study: Astaxanthin Prevents the Onset Of Asthenopia
Company announces the publication of the ninth clinical study on AstaReal® astaxanthin for the reduction of asthenopia (eye fatigue). The effects of astaxanthin on eyestrain induced by accommodative dysfunction were investigated at the University of Occupational and Environmental Health, Department of Ophthalmology, Japan. Results showed a significant improvement in the astaxanthin supplemented group over the placebo group.
- Study: Astaxanthin Prevents the Onset Of Asthenopia
Company announces the publication of the ninth clinical study on AstaReal® astaxanthin for the reduction of asthenopia (eye fatigue). The effects of astaxanthin on eyestrain induced by accommodative dysfunction were investigated at the University of Occupational and Environmental Health, Department of Ophthalmology, Japan. Results showed a significant improvement in the astaxanthin supplemented group over the placebo group.
- Study: Astaxanthin Prevents the Onset Of Asthenopia
Company announces the publication of the ninth clinical study on AstaReal® astaxanthin for the reduction of asthenopia (eye fatigue). The effects of astaxanthin on eyestrain induced by accommodative dysfunction were investigated at the University of Occupational and Environmental Health, Department of Ophthalmology, Japan. Results showed a significant improvement in the astaxanthin supplemented group over the placebo group.
- Study: Astaxanthin Prevents the Onset Of Asthenopia
Company announces the publication of the ninth clinical study on AstaReal® astaxanthin for the reduction of asthenopia (eye fatigue). The effects of astaxanthin on eyestrain induced by accommodative dysfunction were investigated at the University of Occupational and Environmental Health, Department of Ophthalmology, Japan. Results showed a significant improvement in the astaxanthin supplemented group over the placebo group.
- New Nationwide Study Will Evaluate Effect of Antioxidants and Fish Oil on Progression of Age-Related Macular Degeneration (AMD)
The National Institutes of Health (NIH) announces a nationwide study, Age-Related Eye Disease Study 2 (AREDS2), to see if a modified combination of vitamins, minerals, and fish oil can further slow the progression of vision loss from AMD, the leading cause of vision loss in the United States for people over age 60.
- New Nationwide Study Will Evaluate Effect of Antioxidants and Fish Oil on Progression of Age-Related Macular Degeneration (AMD)
The National Institutes of Health (NIH) announces a nationwide study, Age-Related Eye Disease Study 2 (AREDS2), to see if a modified combination of vitamins, minerals, and fish oil can further slow the progression of vision loss from AMD, the leading cause of vision loss in the United States for people over age 60.
- New Nationwide Study Will Evaluate Effect of Antioxidants and Fish Oil on Progression of Age-Related Macular Degeneration (AMD)
The National Institutes of Health (NIH) announces a nationwide study, Age-Related Eye Disease Study 2 (AREDS2), to see if a modified combination of vitamins, minerals, and fish oil can further slow the progression of vision loss from AMD, the leading cause of vision loss in the United States for people over age 60.
- New Nationwide Study Will Evaluate Effect of Antioxidants and Fish Oil on Progression of Age-Related Macular Degeneration (AMD)
The National Institutes of Health (NIH) announces a nationwide study, Age-Related Eye Disease Study 2 (AREDS2), to see if a modified combination of vitamins, minerals, and fish oil can further slow the progression of vision loss from AMD, the leading cause of vision loss in the United States for people over age 60.
- New Nationwide Study Will Evaluate Effect of Antioxidants and Fish Oil on Progression of Age-Related Macular Degeneration (AMD)
The National Institutes of Health (NIH) announces a nationwide study, Age-Related Eye Disease Study 2 (AREDS2), to see if a modified combination of vitamins, minerals, and fish oil can further slow the progression of vision loss from AMD, the leading cause of vision loss in the United States for people over age 60.
- New Study Shows Zeaxanthin and Lutein Supplements Imrove Night Vision and Visual Performance
Study appearing in Ophthalmic and Physiological Optics, The Journal of the College of Optometrists suggests that night vision can be improved by supplementing a diet with lutein and OPTISHARP(TM) brand zeaxanthin.
- New Study Shows Zeaxanthin and Lutein Supplements Imrove Night Vision and Visual Performance
Study appearing in Ophthalmic and Physiological Optics, The Journal of the College of Optometrists suggests that night vision can be improved by supplementing a diet with lutein and OPTISHARP(TM) brand zeaxanthin.
- New Study Shows Zeaxanthin and Lutein Supplements Imrove Night Vision and Visual Performance
Study appearing in Ophthalmic and Physiological Optics, The Journal of the College of Optometrists suggests that night vision can be improved by supplementing a diet with lutein and OPTISHARP(TM) brand zeaxanthin.
- Researchers study supplements to limit damage from macular degeneration
A team of investigators at Washington University School of Medicine in St. Louis and other centers around the United States is evaluating dietary supplements to determine if they can prevent some of the damage from age-related macular degeneration. Some patients also will receive certain omega-3 fatty acids that are contained in fish oils, and others will take supplements containing either lutein and zeaxanthin that normally are made in the retina.
- Researchers study supplements to limit damage from macular degeneration
A team of investigators at Washington University School of Medicine in St. Louis and other centers around the United States is evaluating dietary supplements to determine if they can prevent some of the damage from age-related macular degeneration. Some patients also will receive certain omega-3 fatty acids that are contained in fish oils, and others will take supplements containing either lutein and zeaxanthin that normally are made in the retina.
- Researchers study supplements to limit damage from macular degeneration
A team of investigators at Washington University School of Medicine in St. Louis and other centers around the United States is evaluating dietary supplements to determine if they can prevent some of the damage from age-related macular degeneration. Some patients also will receive certain omega-3 fatty acids that are contained in fish oils, and others will take supplements containing either lutein and zeaxanthin that normally are made in the retina.
- New study shows that a daily supplement of 12 mg lutein from Xangold(R) natural lutein esters increases macular pigment density in adults with early-stage AMD
Study published in the April edition of Experimental Eye Research involved 108 adults who received a daily supplement containing antioxidants - including 12 mg lutein from Xangold(R) lutein esters - for six months and a contro, groupo who recevied no supplements. Results in the intervention group showed substantial increases in blood levels of lutein and a statistically significant average increase of 16% in macular pigment density.
- New study shows that a daily supplement of 12 mg lutein from Xangold(R) natural lutein esters increases macular pigment density in adults with early-stage AMD
Study published in the April edition of Experimental Eye Research involved 108 adults who received a daily supplement containing antioxidants - including 12 mg lutein from Xangold(R) lutein esters - for six months and a contro, groupo who recevied no supplements. Results in the intervention group showed substantial increases in blood levels of lutein and a statistically significant average increase of 16% in macular pigment density.
- New study shows that a daily supplement of 12 mg lutein from Xangold(R) natural lutein esters increases macular pigment density in adults with early-stage AMD
Study published in the April edition of Experimental Eye Research involved 108 adults who received a daily supplement containing antioxidants - including 12 mg lutein from Xangold(R) lutein esters - for six months and a contro, groupo who recevied no supplements. Results in the intervention group showed substantial increases in blood levels of lutein and a statistically significant average increase of 16% in macular pigment density.
- Two new studies boost evidence for the bioavailability and efficacy of Xangold(R) natural lutein esters
In his presentation at the Vitafoods International Supplier Seminar Theatre today (Wednesday, May 9), Holger Becker, Ph.D., cited two new studies which strengthen existing scientific evidence on the bioavailability and efficacy of Xangoldâ natural lutein esters.
- Two new studies boost evidence for the bioavailability and efficacy of Xangold(R) natural lutein esters
In his presentation at the Vitafoods International Supplier Seminar Theatre today (Wednesday, May 9), Holger Becker, Ph.D., cited two new studies which strengthen existing scientific evidence on the bioavailability and efficacy of Xangoldâ natural lutein esters.
- Two new studies boost evidence for the bioavailability and efficacy of Xangold(R) natural lutein esters
In his presentation at the Vitafoods International Supplier Seminar Theatre today (Wednesday, May 9), Holger Becker, Ph.D., cited two new studies which strengthen existing scientific evidence on the bioavailability and efficacy of Xangoldâ natural lutein esters.
- Higher intake of fish and vitamin D levels linked to lower risk of age-related macular disease
Two reports in the May issue of Archives of Ophthalmology indicate that Individuals who have higher dietary intake of foods with omega-3 fatty acids and higher fish consumption have a reduced risk of advanced age-related macular degeneration, while those with higher serum levels of vitamin D may have a reduced risk of the early stages of the disease.
- Higher intake of fish and vitamin D levels linked to lower risk of age-related macular disease
Two reports in the May issue of Archives of Ophthalmology indicate that Individuals who have higher dietary intake of foods with omega-3 fatty acids and higher fish consumption have a reduced risk of advanced age-related macular degeneration, while those with higher serum levels of vitamin D may have a reduced risk of the early stages of the disease.
- Higher intake of fish and vitamin D levels linked to lower risk of age-related macular disease
Two reports in the May issue of Archives of Ophthalmology indicate that Individuals who have higher dietary intake of foods with omega-3 fatty acids and higher fish consumption have a reduced risk of advanced age-related macular degeneration, while those with higher serum levels of vitamin D may have a reduced risk of the early stages of the disease.
- Higher intake of fish and vitamin D levels linked to lower risk of age-related macular disease
Two reports in the May issue of Archives of Ophthalmology indicate that Individuals who have higher dietary intake of foods with omega-3 fatty acids and higher fish consumption have a reduced risk of advanced age-related macular degeneration, while those with higher serum levels of vitamin D may have a reduced risk of the early stages of the disease.
- Tate & Lyle Interim Results Announcement 2009
Tate & Lyle has announced their 2009 Interim results, reporting the Group's performance, before the impact of exchange translation, remains on track to meet our expectations for the full year.
- NPI Daily - Top of The News for Nov. 6, 2009 - National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters
Nature's Sunshine Products Reports FY09 Q3 Operating Results; SunOpta Announces FY09 Q3 Results; Tate & Lyle Interim Results Announcement 2009; NOW Foods Receives the 2009 Illinois Governor's Sustainability Award; Transport-C Supports Vitamin Angels at SSW; Cantox at Supplyside West; New Support Showing Immunoglobulin Supplementation Enhances Immune System; FDA Warning: Over-the-Counter Sex Enhancement Drug May Cause 'Dangerously' Low Blood Pressure; EPAX AS Achieves 'Friend of the Sea' Certification; National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters; Fast-C™ At SupplySide West: US Clinical Trials Data Available In Booth ; Nutty Flavor & Healthy Boost of Omega-3 Make Hemp Seed an Ideal Ingredient; DSM's tensVida® Recognized for Innovative Development; Nutrition 21 Announces Addition of Innovative New Probiotic + Omega-3 Fish Oil Combination Product; Glanbia Nutritionals Offers More Than Ingredients for Nutritional Beverages; Whole Foods Market(R) Offers Natural Solutions to Help Build Up Body Defenses With Immune System Support; Doug Reyes Joins Embria as Regional Sales Manager; Michael F. Hines Joins Board of General Nutrition Centers, Inc.; Dr. Arnold Hirsch Celebrates 50th Anniversary with the American Chemical Society
- NPI Daily - Top of The News for Nov. 6, 2009 - National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters
Nature's Sunshine Products Reports FY09 Q3 Operating Results; SunOpta Announces FY09 Q3 Results; Tate & Lyle Interim Results Announcement 2009; NOW Foods Receives the 2009 Illinois Governor's Sustainability Award; Transport-C Supports Vitamin Angels at SSW; Cantox at Supplyside West; New Support Showing Immunoglobulin Supplementation Enhances Immune System; FDA Warning: Over-the-Counter Sex Enhancement Drug May Cause 'Dangerously' Low Blood Pressure; EPAX AS Achieves 'Friend of the Sea' Certification; National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters; Fast-C™ At SupplySide West: US Clinical Trials Data Available In Booth ; Nutty Flavor & Healthy Boost of Omega-3 Make Hemp Seed an Ideal Ingredient; DSM's tensVida® Recognized for Innovative Development; Nutrition 21 Announces Addition of Innovative New Probiotic + Omega-3 Fish Oil Combination Product; Glanbia Nutritionals Offers More Than Ingredients for Nutritional Beverages; Whole Foods Market(R) Offers Natural Solutions to Help Build Up Body Defenses With Immune System Support; Doug Reyes Joins Embria as Regional Sales Manager; Michael F. Hines Joins Board of General Nutrition Centers, Inc.; Dr. Arnold Hirsch Celebrates 50th Anniversary with the American Chemical Society
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Taming Fear of the H1N1 Flu Vaccine
- Taming Fear of the H1N1 Flu Vaccine
- Natural Cold and Flu Remedies: Do They Help?
- Natural Cold and Flu Remedies: Do They Help?
- Exercise as Pain Therapy
- Exercise as Pain Therapy
|
French Researchers Find Strong Evidence That Zeaxanthin Is Helpful In Preventing AMD And Cataracts
West Chicago, IL (June 27, 2006) – As the benefits of antioxidants like zeaxanthin on eye health continue to receive validation from a variety of sources, demand for information on zeaxanthin is increasing. A comprehensive, easily accessible abstract collection is readily available on the web site www.Chrysantis.com.
The site’s research tab includes abstracts of more than 30 studies published beginning in 1990 and continuing to the present. It also includes a comprehensive exploration of the structure and function of zeaxanthin, a description of carotenoids, information on Age Related Macular Degeneration (AMD), links to related organizations such as the National Eye Institute and the Macular Degeneration Partnership, a recap of the Lewin Study from November 2005 that estimated a $2.5 billion net health care savings over five years through lutein and zeaxanthin supplementation, and many other related pieces of information.
“Part of our mission is to provide education regarding the benefits of this powerful antioxidant,” said Chrysantis general manager Manuel Pavon. “Manufacturers adding zeaxanthin to eye health products and consumers interested in preserving their vision can find the latest and most relevant scientific references in our web site.”
The most recent addition is the study conducted by the Ocular Pathologies Associated with Age group (POLA in French). An article published in the Investigative Ophthalmology and Visual Science June 2006 issue reports finding a particularly strong inverse association between plasma zeaxanthin and AMD: subjects with high levels of plasma zeaxanthin (>0.9μM) had a 93% reduced risk of AMD. Globally, subjects with high total plasma lutein and zeaxanthin (>0.56μM) had a 79% reduced risks of AMD compared with subjects with low total plasma lutein and zeaxanthin (<0.25μM).
The researchers also found that only plasma zeaxanthin (of all carotenoids) showed a strong inverse association with nuclear cataracts. Subjects with high plasma zeaxanthin (>0.9μM) had a 75% decrease risk of developing this type of cataract.
The results of this study are consistent with those reported by Dr. Catherine Gale in 2003. Dr. Gale reported a significant (50%) reduced risk of early or late AMD in subjects with high plasma zeaxanthin (>0.05μM), compared with subjects with low levels (<0.03μ). The associations in this study were even stronger, perhaps because of the higher values in the highest quintile of zeaxanthin and lutein in this Mediterranean population, probably associated with higher dietary intakes of these xanthophylls.
Chrysantis, Inc., a wholly owned subsidiary of Ball Horticultural Company based in West Chicago, IL, is dedicated to developing high-quality plant-based products for dietary supplement manufacturers and the functional foods industry that will enhance human health. Family-owned Ball Horticultural Company has been researching, breeding and selling the highest-quality flower seed varieties for 100 years.
For more information, call 630 588-3474 or visit www.Chrysantis.com.
-- END – |